Liposomal daunorubicin (DaunoXome) for treatment of relapsed meningeal acute myeloid leukemia

被引：0
作者：
PP Piccaluga
G Visani
G Martinelli
A Isidori
M Malagola
M Rondoni
M Baccarani
S Tura
机构：
[1] Institute of Haematology and Clinical Oncology,Department of Hematology
[2] ‘L and A Seràgnoli’,undefined
[3] University of Bologna,undefined
[4] S Salvatore Hospital,undefined
来源：
Leukemia | 2002年 / 16卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1880 / 1881
页数：1
相关论文
共 60 条
  • [1] Leith CP(1999)Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glicoprotein, MRP1, and LRP in acute myeloid leukemia: a Southwest Oncology Group Study Blood 94 1086-1099
  • [2] Kopecky KJ(1997)Molecular remission in PML/RARa-positive acute promyelocytic leukemia by combined all- Blood 90 1014-1021
  • [3] Chen IM(1999) retinoic acid and idarubicin (AIDA) therapy Br J Haematol 106 92-99
  • [4] Eijdems L(2000)Liposome-encapsulated daunorubicin for Pgp-related multidrug resistance Haematologica 85 324-325
  • [5] Slovak ML(1999)Liposome encapsulated daunorubicin (DaunoXome) for acute leukemia Ped Hematol Oncology 16 131-139
  • [6] McConnell TS(2001)Liposomal daunorubicin (Daunoxome) in children with recurrent or progressive brain tumors Cancer 92 7-14
  • [7] Head DR(undefined)High-dose liposomal daunorubicin and high-dose cytarabine combination in patients with refractory or relapsed acute myelogenous leukaemia undefined undefined undefined-undefined
  • [8] Weick J(undefined)undefined undefined undefined undefined-undefined
  • [9] Grever MR(undefined)undefined undefined undefined undefined-undefined
  • [10] Appelbaum FR(undefined)undefined undefined undefined undefined-undefined
123456